Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#11 / 100 Total
NEWT - NewtekOne Inc - Stock Price Chart
TickerNEWT [NASD, RUT]
CompanyNewtekOne Inc
CountryUSA
IndustryBanks - Regional
Market Cap355.63MEPS (ttm)1.55
P/E8.98EPS this Y12.16%
Forward P/E6.51EPS next Y11.71%
PEG2.99EPS past 5Y-0.24%
P/S1.31EPS next 5Y3.00%
P/B1.46EPS Q/Q-16.44%
Dividend5.48%Sales Q/Q41.92%
Insider Own6.76%Inst Own36.13%
Insider Trans0.87%Inst Trans-10.44%
Short Float7.88%EarningsMay 06/a
Analyst Recom2.67Target Price13.75
Avg Volume149.91K52W Range10.07 - 19.36
NewtekOne, Inc. is a financial holding company, which engages in the provision of business and financial solutions. Its brands include Newtek Bank, Newtek Lending, Newtek Payments, Newtek Insurance, Newtek Payroll, and Newtek Technology. The company was founded by Barry Sloane in 1998 and is headquartered in Boca Raton, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SLOANE BARRYChairman & CEOMay 15 '24Buy14.1710,000141,7161,130,674May 15 10:03 AM
Zink Gregory LDirectorMay 15 '24Buy14.151,00014,15228,085May 15 10:34 AM
Mulia Salvatore FrancisDirectorApr 22 '24Sale10.877508,15246,462Apr 23 04:14 PM
Mulia Salvatore FrancisDirectorMar 21 '24Sale10.717508,03347,212Mar 22 04:04 PM
Mulia Salvatore FrancisDirectorFeb 21 '24Sale11.487508,61047,962Feb 21 05:12 PM
KRNY - Kearny Financial Corp. - Stock Price Chart
TickerKRNY [NASD, RUT]
CompanyKearny Financial Corp.
CountryUSA
IndustryBanks - Regional
Market Cap383.42MEPS (ttm)0.24
P/E24.62EPS this Y-48.41%
Forward P/E11.02EPS next Y66.15%
PEG6.15EPS past 5Y21.58%
P/S1.19EPS next 5Y4.00%
P/B0.44EPS Q/Q-25.31%
Dividend7.39%Sales Q/Q9.48%
Insider Own12.10%Inst Own61.81%
Insider Trans0.25%Inst Trans-11.79%
Short Float1.82%EarningsApr 25/b
Analyst Recom3.00Target Price6.25
Avg Volume454.34K52W Range5.28 - 9.46
Kearny Financial Corp. operates as a holding company, which engages in the ownership and operation of Kearny Bank. Its services include deposits from the general public in New Jersey. The firm uses deposits, together with other funds, to originate or purchase loans for its portfolio and invest in securities. It offers both personal and business services. The company was founded in 1884 and is headquartered in Fairfield, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pivirotto Charles JDirectorMay 13 '24Buy5.765,16029,73959,573May 15 09:44 AM
Suchodolski KeithSEVP and CFOMar 18 '24Buy5.872,00011,74082,648Mar 18 11:16 AM
BILOTTA ANTHONY V JREVP and Chief Banking OfficerMar 18 '24Buy5.852,00011,70079,761Mar 18 11:14 AM
Joyce Patrick MEVP and CLOMar 14 '24Sale6.173,50021,59748,331Mar 14 01:51 PM
Wong-Zaza MelvinaDirectorFeb 14 '24Buy6.473,94525,5156,595Feb 15 09:45 AM
NVCT - Nuvectis Pharma Inc - Stock Price Chart
TickerNVCT [NASD, RUT]
CompanyNuvectis Pharma Inc
CountryUSA
IndustryBiotechnology
Market Cap121.73MEPS (ttm)-1.37
P/E-EPS this Y9.79%
Forward P/E-EPS next Y-9.30%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B8.68EPS Q/Q8.40%
Dividend-Sales Q/Q-
Insider Own60.91%Inst Own8.34%
Insider Trans0.09%Inst Trans28.35%
Short Float13.15%EarningsMay 07/b
Analyst Recom1.00Target Price22.00
Avg Volume103.86K52W Range5.92 - 18.65
Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product pipeline includes NXP800 and NXP900. The company was founded by Ron Bentsur, Enrique Poradosu and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BENTSUR RONChairman & CEOMay 14 '24Buy6.741,94013,0763,246,424May 15 09:16 AM
BENTSUR RONChairman & CEOMay 10 '24Buy6.402,00012,8003,244,484May 13 08:51 AM
Shemesh ShayChief Dev. & Ops. OfficerMay 10 '24Buy6.321,1137,0341,493,068May 13 08:47 AM
Poradosu EnriqueChief Science & Business OffMay 10 '24Buy6.295003,1451,504,319May 13 08:49 AM
BENTSUR RONChairman & CEOMar 18 '24Buy10.295,00051,4503,242,484Mar 19 08:00 AM
LSAK - Lesaka Technologies Inc - Stock Price Chart
TickerLSAK [NASD]
CompanyLesaka Technologies Inc
CountrySouth Africa
IndustrySoftware - Infrastructure
Market Cap311.64MEPS (ttm)-0.37
P/E-EPS this Y42.18%
Forward P/E123.67EPS next Y127.81%
PEG-EPS past 5Y-
P/S0.57EPS next 5Y15.00%
P/B1.83EPS Q/Q30.41%
Dividend-Sales Q/Q3.15%
Insider Own32.34%Inst Own23.92%
Insider Trans1.86%Inst Trans1.08%
Short Float0.18%EarningsMay 08/a
Analyst Recom1.00Target Price8.00
Avg Volume17.80K52W Range3.00 - 5.33
Lesaka Technologies, Inc. is a South African financial technology company which focuses on delivering financial services to consumers (B2C) and merchants (B2B) in Southern Africa through proprietary banking and payment technologies. Its services include banking, lending and insurance solutions to consumers, cash management solutions, bill payment technology, value-added services, business funding and card acquiring solutions to formal and informal retail merchants. The company was founded by Serge Christian Pierre Belamant in 1989 and is headquartered in Johannesburg, South Africa.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mazanderani AliExecutive ChairmanMay 14 '24Buy5.1452,418269,429374,894May 15 09:11 AM
Mazanderani AliDirectorDec 12 '23Buy3.30322,4761,064,171322,476Dec 13 04:09 PM
Value Capital Partners (Pty) LDirectorJun 29 '23Buy3.577,30326,07215,642,598Jul 03 04:01 PM
Value Capital Partners (Pty) LDirectorJun 21 '23Buy3.601,2004,32015,635,295Jun 26 07:57 PM
Value Capital Partners (Pty) LDirectorMay 25 '23Buy3.594001,43615,634,095May 30 08:32 PM
HAIN - Hain Celestial Group Inc - Stock Price Chart
TickerHAIN [NASD, RUT]
CompanyHain Celestial Group Inc
CountryUSA
IndustryPackaged Foods
Market Cap664.37MEPS (ttm)-1.01
P/E-EPS this Y-41.78%
Forward P/E17.15EPS next Y48.17%
PEG-EPS past 5Y-
P/S0.38EPS next 5Y-
P/B0.70EPS Q/Q58.55%
Dividend-Sales Q/Q-3.71%
Insider Own1.39%Inst Own102.50%
Insider Trans3.18%Inst Trans5.17%
Short Float4.22%EarningsMay 08/b
Analyst Recom2.47Target Price9.77
Avg Volume1.45M52W Range5.68 - 14.20
The Hain Celestial Group, Inc. engages in the production and distribution of organic and natural products. It operates through North America and International geographical segments. The North America segment consists of the United States and Canada. The International segment includes the United Kingdom, Ella's Kitchen UK, and Europe. The company was founded by Irwin David Simon on May 19, 1993 and is headquartered in Hoboken, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Boyce Lee A.EVP & Chief Financial OfficerMay 13 '24Buy7.6713,500103,47813,500May 15 08:36 AM
Marquardt Chad D.President, North AmericaMay 10 '24Buy6.9510,00069,50010,000May 13 08:34 AM
Davidson Wendy PPresident and CEOMay 10 '24Buy6.995,00034,93463,309May 13 08:31 AM
Davidson Wendy PPresident and CEOFeb 13 '24Buy9.465,00047,29458,309Feb 14 04:19 PM
ZIER DAWN M.DirectorNov 15 '23Buy11.255,00056,25068,755Nov 16 04:30 PM
BHVN - Biohaven Ltd - Stock Price Chart
TickerBHVN [NYSE, RUT]
CompanyBiohaven Ltd
CountryUSA
IndustryBiotechnology
Market Cap3.27BEPS (ttm)-6.84
P/E-EPS this Y-27.46%
Forward P/E-EPS next Y10.06%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B10.04EPS Q/Q-112.85%
Dividend-Sales Q/Q-
Insider Own14.67%Inst Own87.35%
Insider Trans3.38%Inst Trans334.79%
Short Float11.83%EarningsMay 09/a
Analyst Recom1.09Target Price58.67
Avg Volume1.40M52W Range13.53 - 62.21
Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CHILDS JOHN WDirectorMay 13 '24Buy35.1728,5001,002,4702,283,341May 14 07:30 AM
Bailey GregoryDirectorMay 13 '24Buy34.1915,000512,8771,615,071May 15 07:31 AM
Bailey GregoryDirectorApr 24 '24Buy39.1825,503999,1691,600,071Apr 25 07:32 AM
CHILDS JOHN WDirectorApr 22 '24Buy41.00195,1217,999,9614,096,512Apr 23 07:54 AM
Coric VladChief Executive OfficerApr 22 '24Buy41.00121,9514,999,9911,788,417Apr 23 07:54 AM
BCRX - Biocryst Pharmaceuticals Inc. - Stock Price Chart
TickerBCRX [NASD, RUT]
CompanyBiocryst Pharmaceuticals Inc.
CountryUSA
IndustryBiotechnology
Market Cap1.31BEPS (ttm)-1.07
P/E-EPS this Y47.50%
Forward P/E-EPS next Y42.00%
PEG-EPS past 5Y-3.73%
P/S3.68EPS next 5Y44.80%
P/B-EPS Q/Q39.31%
Dividend-Sales Q/Q34.87%
Insider Own3.68%Inst Own83.36%
Insider Trans2.06%Inst Trans-1.64%
Short Float16.92%EarningsMay 06/b
Analyst Recom1.33Target Price14.00
Avg Volume3.38M52W Range4.03 - 8.96
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Doyle AnthonyChief Financial OfficerMay 14 '24Buy5.5736,300202,191266,744May 15 07:19 AM
Thackray Helen M.Chief R&D OfficerMay 14 '24Buy5.8630,000175,800272,139May 15 07:17 AM
Stonehouse Jon PPresident & CEOMay 13 '24Buy5.5530,000166,5001,127,770May 15 07:08 AM
Gayer Charles KChief Commercial OfficerMay 13 '24Buy5.4730,000164,100307,533May 15 07:04 AM
Galson Steven KDirectorMay 13 '24Buy5.4921,940120,45151,551May 15 07:14 AM
UNOV - Innovator U.S. Equity Ultra Buffer ETF - November - Stock Price Chart
TickerUNOV [AMEX]
CompanyInnovator U.S. Equity Ultra Buffer ETF - November
CountryUSA
IndustryExchange Traded Fund
CategoryUS Equities - Quant Strat
IndexSPDR S&P 500 ETF Trust
TagsU.S., options, SP500, buffer, upside-cap, fixed-period
Sector/Theme Region
Dividend-Active/Passive
Total Holdings5AUM41.21M
Flows% 1M-24.19%Flows% 3M-29.48%
Flows% YTD-28.51%Flows% 1Y
Return% 1Y12.87%Return% 3Y0.05%
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume13.45K52W Range29.07 - 32.99
Apr-01-20 09:00AM Innovator Expands Category-Creating Defined Outcome ETF Suite with April Series of Nasdaq 100 and Russell 2000 Power Buffer Listings, Announces New Upside Caps for April Series of S&P 500 Buffer ETFs (ACCESSWIRE)
Mar-23-20 09:00AM Innovator Preps Defined Outcome ETF Expansion with April Series of Nasdaq 100, Russell 2000, MSCI EAFE, and Emerging Markets Power Buffer Listings, Announces New Upside Cap Ranges for April S&P 500 Buffer ETFs (ACCESSWIRE)
Mar-02-20 09:00AM Innovator Expands Defined Outcome Suite Listing March Series of S&P 500 Buffer ETFs (ACCESSWIRE)
Feb-21-20 09:00AM Innovator Announces Upside Cap Ranges for March Series of S&P 500 Buffer ETFs (ACCESSWIRE)
Feb-03-20 09:00AM Innovator Expands Defined Outcome Suite Listing February Series of S&P 500 Buffer ETFs (ACCESSWIRE)
Jan-27-20 09:00AM Innovator Announces Upside Cap Ranges for February Series of S&P 500 Buffer ETFs (ACCESSWIRE)
Jan-08-20 10:46AM Innovator Announces Successful Completion of Initial Outcome Period for January Series of S&P 500 Buffer ETFs (ACCESSWIRE)
Jan-02-20 09:00AM Innovator Expands Defined Outcome Suite Listing January Series of Nasdaq 100, Russell 2000, MSCI EAFE, and MSCI Emerging Markets Power Buffer ETFs (ACCESSWIRE)
Dec-31-19 07:00PM Innovator Announces New Upside Caps for January Series of S&P 500 Buffer ETFs (ACCESSWIRE)
Dec-27-19 09:00AM Innovator Preps Nasdaq 100, Russell 2000, MSCI EAFE, and MSCI Emerging Markets Buffer ETF Listings, Announces Upside Cap Ranges for S&P 500 January Series of Defined Outcome Buffer ETFs (ACCESSWIRE)
Innovator U.S. Equity Ultra Buffer ETF - November seeks to provide investors with returns that match the price return of the SPDR S&P 500 ETF Trust. The fund invests at least 80% of its net assets in FLexible EXchange Options ("FLEX Options") that reference the SPDR S&P 500 ETF Trust (the "Underlying ETF"). FLEX Options are exchange-traded options contracts with uniquely customizable terms. Although guaranteed for settlement by the Options Clearing Corporation (the "OCC"), FLEX Options are still subject to counterparty risk with the OCC and may be less liquid than more traditional exchange-traded options. It is non-diversified.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sanchez Yovan ArturoDirectorMay 14 '24Buy0.14150,00020,250910,500May 15 06:13 AM
Sanchez Yovan ArturoDirectorMay 10 '24Buy0.1010,5001,050760,500May 13 02:23 PM
Saumat Giorgio R.CEOMay 06 '24Buy0.1020,0001,900121,238,579May 07 12:08 PM
Saumat Giorgio R.CEOMay 03 '24Buy0.10100,00010,350121,218,579May 03 06:32 PM
Saumat Giorgio R.CEOMay 02 '24Buy0.10709,84168,759121,118,579May 03 06:15 AM
IMMX - Immix Biopharma Inc - Stock Price Chart
TickerIMMX [NASD]
CompanyImmix Biopharma Inc
CountryUSA
IndustryBiotechnology
Market Cap63.12MEPS (ttm)-0.95
P/E-EPS this Y-24.00%
Forward P/E-EPS next Y-8.60%
PEG-EPS past 5Y-63.30%
P/S-EPS next 5Y-
P/B2.26EPS Q/Q-25.78%
Dividend-Sales Q/Q-
Insider Own47.54%Inst Own12.45%
Insider Trans0.52%Inst Trans19.80%
Short Float2.80%Earnings-
Analyst Recom1.00Target Price14.00
Avg Volume180.96K52W Range1.40 - 7.75
Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Morris Gabriel SCFOMay 14 '24Buy2.234,50010,04285,816May 14 09:29 PM
Rachman Ilya MCEO and ChairmanMay 14 '24Buy2.254,3009,660912,000May 14 09:28 PM
Hsu JasonDirectorDec 11 '23Buy4.6731,000144,894813,000Dec 12 06:25 PM
Hsu JasonDirectorDec 08 '23Buy4.8825,000122,025782,000Dec 12 06:25 PM
Hsu JasonDirectorSep 15 '23Buy2.497,00017,396757,000Sep 18 07:03 PM
CPNG - Coupang Inc - Stock Price Chart
TickerCPNG [NYSE]
CompanyCoupang Inc
CountryUSA
IndustryInternet Retail
Market Cap40.28BEPS (ttm)0.70
P/E32.00EPS this Y-74.23%
Forward P/E38.77EPS next Y200.71%
PEG-EPS past 5Y-
P/S1.57EPS next 5Y-
P/B9.91EPS Q/Q-94.66%
Dividend-Sales Q/Q22.64%
Insider Own34.60%Inst Own52.27%
Insider Trans-11.13%Inst Trans0.00%
Short Float2.41%EarningsMay 07/a
Analyst Recom1.82Target Price25.77
Avg Volume15.56M52W Range13.51 - 23.77
Coupang, Inc. engages in operating an e-commerce platform. It operates through the following segments: Product Commerce and Developing Offerings segments. The Product Commerce segment provides core retail and marketplace offerings and Rocket Fresh, as well as advertising products associated with these offerings. The Developing Offerings segment includes nascent offerings and services, including Coupang Eats, Coupang Play, international and fintech initiatives. The company was founded in 2010 and is headquartered in Seattle, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GREENOAKS CAPITAL PARTNERS LLCDirectorMay 14 '24Buy22.28298,5506,650,44048,924,924May 14 09:00 PM
GREENOAKS CAPITAL PARTNERS LLCDirectorMay 13 '24Buy22.06500,00011,029,95048,626,374May 14 09:00 PM
GREENOAKS CAPITAL PARTNERS LLCDirectorMay 10 '24Buy22.53120,2392,709,05748,126,374May 14 09:00 PM
Lee Jonathan D.Chief Accounting OfficerMay 09 '24Sale21.455,000107,250120,835May 10 04:38 PM
Kolari PranamSee RemarksMay 02 '24Sale22.342,04845,752187,951May 03 04:48 PM
12345678910